EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Healthcare professional perspectives on hereditary breast cancer risk assessment prior to gender-affirming mastectomy

Kimberly Zayhowski, Kai Blumen, Kathleen F Mittendorf, Rebekah Pratt, Tala Berro, Carl Streed, Ian M MacFarlane

Breast Cancer Research and Treatment · 2026-07 · 218 (2)

DOI: 10.1007/s10549-026-08038-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Cancer Research and Treatment, online erschienen am 29.07.2026. Verfasst von Kimberly Zayhowski und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medical Sciences and Education, Boston University Chobanian and Avedisian School of Medicine, 72 East Concord Street, Boston, MA, 02118, USA. kzayhow…. Hauptthemen laut MEDLINE: Breast Neoplasms, Mastectomy, Health Personnel, Gender-Affirming Surgery. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Society of Genetic Counselors, United States.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Transgender and gender diverse (TGD) individuals undergoing gender-affirming mastectomy (GAM) face unique challenges related to breast cancer risk assessment and screening. This study aimed to identify factors that influence healthcare professionals’ (HCPs) integration of cancer risk evaluation, including genetic assessment, within the context of GAM and pre-surgical planning.

Methods

We conducted semi-structured qualitative interviews with 20 healthcare professionals - including six primary care providers, five cancer genetic counselors, six oncologists, and three plastic surgeons - experienced in caring for TGD patients considering or undergoing GAM. Using a social constructivist framework, we applied reflexive thematic analysis to explore HCP perspectives and generate key themes.

Results

We conceptualized five key themes: (1) HCPs perceive no clear ownership for care integration of breast cancer risk assessment; (2) conflicting guidelines force HCPs to rely on their own judgment, resulting in inconsistent practice; (3) care pathways are driven by individual HCP champions rather than standardized protocols; (4) GAM frequently occurs at young ages prior to age of population cancer risk screening initiation, complicating risk discussions; and (5) structural failures in care delivery compromise patient safety.

Conclusion

Improving cancer risk assessment for TGD patients undergoing GAM demands clear institutional accountability, harmonized evidence-based guidelines, standardized care pathways, and genetic counseling embedded into multidisciplinary gender-affirming care teams. These coordinated structural efforts are critical to integrate equitable, personalized, and patient-centered cancer prevention with gender-affirming surgical care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsMastectomyHealth PersonnelGender-Affirming SurgeryAttitude of Health PersonnelHumansFemaleRisk AssessmentTransgender PersonsMaleAdultMiddle AgedGenetic CounselingGenetic Predisposition to Disease

Stichwörter der Autor:innen

Breast cancerGender-affirming careGenetic counselingMastectomyReflexive thematic analysisTransgender

Autor:innen und Institutionen

  • Medical Sciences and Education, Boston University Chobanian and Avedisian School of Medicine, 72 East Concord Street, Boston, MA, 02118, USA. kzayhows@bu.edu.
  • Department of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, MN, USA. kzayhows@bu.edu.
  • Master's Program in Genetic Counseling, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA.
  • Lavender Spectrum Health, Vancouver, WA, USA.
  • Department of Family Medicine and Community Health, University of Minnesota, Minneapolis, USA.
  • Department of Genetics, Kaiser Permanente, Oakland, CA, USA.

Förderung

  • National Society of Genetic Counselors, United States

Zitieren

APA

Zayhowski, K., Blumen, K., Mittendorf, K. F., Pratt, R., Berro, T., Streed, C., & MacFarlane, I. M. (2026). Healthcare professional perspectives on hereditary breast cancer risk assessment prior to gender-affirming mastectomy. Breast Cancer Research and Treatment, 218(2). https://doi.org/10.1007/s10549-026-08038-9

Vancouver

Zayhowski K, Blumen K, Mittendorf KF, Pratt R, Berro T, Streed C, et al. Healthcare professional perspectives on hereditary breast cancer risk assessment prior to gender-affirming mastectomy. Breast Cancer Research and Treatment. 2026;218(2). doi:10.1007/s10549-026-08038-9

BibTeX
@article{Zayhowski2026,
  author = {Zayhowski, Kimberly and Blumen, Kai and Mittendorf, Kathleen F and Pratt, Rebekah and Berro, Tala and Streed, Carl and MacFarlane, Ian M},
  title = {Healthcare professional perspectives on hereditary breast cancer risk assessment prior to gender-affirming mastectomy},
  journal = {Breast Cancer Research and Treatment},
  year = {2026},
  volume = {218},
  number = {2},
  doi = {10.1007/s10549-026-08038-9}
}
Kostenlos starten →